Union Budget 2026-27: Government Launches Biopharma Shakti with ₹10,000 Cr Outlay over 5 years to Position India as a Global Bio‑Pharma Hub [Read Finance Bill 2026]
Biopharma Shakti, announced in the Union Budget 2026‑27 with a ₹10,000 crore outlay over five years, aims to make India a global hub for biopharmaceutical manufacturing.
The Union Budget for the Financial Year 2026-27 was presented by Finance Minister Nirmala Sitharaman in the Lok Sabha today (Sunday, 1 February 2026).
Among many announcements made during the Union Budget 2026 presentation, Finance Minister Nirmala Sitharaman proposed biophar shakti, a flagship initiative with a ₹10,000 crore outlay spread over five years.
In her speech, she emphasises that the programme is designed to boost India's emergence as a global biopharma hub by strengthening research and innovation, as well as manufacturing capabilities, in biotechnology and pharmaceuticals.
She focused on that. This strategic investment underscores the country’s commitment to fostering cutting‑edge healthcare solutions, boosting industry competitiveness, and positioning India at the forefront of the global life sciences sector.
Let AI handle GST returns, notices, and litigation - Click Here to know more
This strategic move comes at a time when the nation’s disease burden is increasingly shifting towards non‑communicable diseases such as diabetes, cancer, and other chronic conditions, making advanced therapies more critical than ever.
To support this vision, the government has committed to strengthening drug regulatory systems and expanding clinical trial infrastructure, ensuring that India not only scales up production capacity but also adheres to global standards of safety, efficacy, and innovation.
Also, this initiative aligns with the government’s broader growth and industry‑building agenda.
Biopharma Shakti aims to make advanced therapies more accessible, foster industry competitiveness, and position India at the forefront of life sciences innovation
This calculated investment underscores the government’s commitment to both public health and economic growth, aligning with its vision of knowledge‑driven development in strategic sectors.
Support our journalism by subscribing to Taxscan premium. Follow us on Telegram for quick updates
